Biocon Shares Rise 4% as US FDA Approves Biosimilar Yesintek
Shares of Biocon jumped over 4% in intraday trade on December 2 after the US FDA approved Biocon Biologics’ Yesintek, a biosimilar to Johnson & Johnson’s Stelara. At 12:10 PM, shares of Biocon were trading 3% higher at ₹375. For the stock, it was the seventh straight session of gains. The stock has gained 47% […]
Biocon Shares Rise 4% as US FDA Approves Biosimilar Yesintek Read More »